Kintara Therapeutics Inc (STU:3DMA)
€ 0.227 -0.088 (-27.94%) Market Cap: 11.31 Mil Enterprise Value: 14.89 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Kintara Therapeutics Inc to Host KOL Event (Virtual) Transcript

Aug 21, 2023 / 03:00PM GMT
Release Date Price: €3.18
Operator

Good afternoon and welcome to the Kintara Therapeutics key opinion leader event. (Operator Instructions) As a reminder, today's call will be recorded and a replay will be made available on the Kintara Therapeutics' website following the conclusion of the event.

With that, I would like to turn the call over to your host, Chief Executive Officer of Kintara Therapeutics, Robert Hoffman. Please go ahead, Robert.

Robert Hoffman
Kintara Therapeutics, Inc. - President, CEO, CFO and Chairman of the Board

Thank you, Sarah, and welcome, everyone. Thank you for attending our key opinion leader. We're really excited to have Dr. Wen and Dr. de Groot to give a short presentation and answer any questions that you have.

Next slide. Here's the agenda. I'll give a brief introduction. Dr. de Groot will go through the unmet medical need in glioblastoma or GBM. Dr. Wen will explore the treatment landscape and VAL-083's potential role, if approved. Dennis Brown, our Chief Scientific Officer, will go through the scientific rationale and mechanism of action of VAL

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot